期刊文献+

卡培他滨联合放疗治疗消化道肿瘤的临床观察 被引量:14

Clinical Efficacy of Radiotherapy Combined with Capecitabine for Gastrointestinal Tumor
暂未订购
导出
摘要 目的:观察卡培他滨联合放疗与单纯放疗治疗消化道恶性肿瘤的疗效。方法:52例有腹腔内可评价病灶的消化道恶性肿瘤病例,分为放疗与卡培他滨联合组(治疗组)26例和单纯放疗组(对照组)26例,治疗组接受腹腔病灶三维适形放疗DT=60-65Gy,同时口服卡培他滨1.5bid共14天,每21天为1周期,共6个周期,对照组只接受腹腔病灶三维适形放疗,DT=60-65Gy,治疗过程中观察毒性反应,放疗结束后2个月评价疗效,观察疾病进展时间(TTP)、1年及2年生存率。结果:治疗组退出试验者3例,可评价病例23例,有效率78.3%(18/23),对照组有效率61.5%(16/26),治疗组TTP10个月,对照组5.5个月,P<0.05,治疗组1年及2年生存率为60.1%和47.8%,对照组为46.2%和19.2%,1年生存率无差异(P>0.05),2年生存率有差异(P<0.05)。结论:卡培他滨同步放疗治疗消化道恶性肿瘤,较单纯放疗能延长疾病进展时间,提高2年生存率,但对有效率、1年生存率无影响。 OBJECTIVE:To observe the efficacy of radiotherapy alone or in combination with capecitabine for gastrointestinal tumor.METHODS:52 malignant gastrointestinal tumor cases with evaluable nidus in abdominal cavity were divided into two groups:26 cases in treatment group received three-dimensional radiotherapy(DT = 60-65 Gy) combined with capecitabine(1.5 bid on the first 14 days) for 6 cycles,every cycle consisted of 21 days;and 26 cases in control group received three-dimensional radiotherapy(DT = 60-65 Gy) alone.The toxicity during treatment,the efficacy at 2 months after completion of radiotherapy,the time to progression(TTP) and one-and two-year survival rates were recorded.RESULTS:In the treatment group,3 cases withdrew from the experiment,which left 23 cases under evaluation.The effective rate in the treatment group was 78.3%(18 /23) as compared with 61.5%(16 /26) of the control group.The treatment group had longer median time to progression compared with control group(10 mon vs.5.5 mon,P 0.05),one-and two-year survival rates were 60.1% and 21.7% in the treatment group versus 46.2% and 23.1% in the control group,showing no significant differences in one-year survival rates(P 0.05) but significant differences were noted in two-year survival rates(P 0.05).CONCLUSION:Compared with three-dimensional radiotherapy alone,capecitabine combined with three dimensional radiotherapy prolongs the median time to progression and increases two-year survival rates yet without affecting total effect rate and one-year survival rate for patients with gastrointestinal tumor.
出处 《中国医院用药评价与分析》 2010年第6期545-547,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 消化道肿瘤 三维适形放疗 卡培他滨 Gastrointestinal tumor Three-dimensional radiotherapy Capecitabine
  • 相关文献

参考文献10

  • 1文世民,李光明,潘荣强,胡欣.立体定向适形放射治疗腹部恶性肿瘤的临床评价[J].华西医学,2004,19(1):113-113. 被引量:1
  • 2NCCN胃癌临床实践指南(中国版)专家组.NCCN胃癌临床实践指南(中国版)[s].第2版.2009.
  • 3NCCN结肠癌临床实践指南(中国版)专家组.NCCN结肠癌临床实践指南(中国版)[s].第1版.2009.
  • 4NCCN直肠癌临床实践指南(中国版)专家组.NCCN直肠癌临床实践指南(中国版)[s].第1版.2009.
  • 5Rich T. Capecitabine and radiation therapy for advanced gastrointestinal malignancies [ J ]. Oncology ( Williston Park) ,2002 ,16(12 Suppl No 14):27.
  • 6孙菁,孙益红,秦新裕,曾蒙苏,王敏桦,曾昭冲.胃癌术后腹腔淋巴结转移放疗的疗效分析[J].中华放射肿瘤学杂志,2007,16(4):277-280. 被引量:10
  • 7安富荣,戈升荣,祝德秋.卡培他滨的药理特性及临床应用进展[J].中国新药与临床杂志,2002,21(8):503-507. 被引量:51
  • 8Sawada N, Ishikawa T, Sekiguchi F, et al. X - ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts[J]. Clin CancerRes, 1999, 5(10):2 948.
  • 9凌云华,吴洪斌,吴薇,徐红冰,奚菁颖,陈志东,温燕,陶静,陆国椿,陆益,沈敏.119例口服卡培他滨片不良反应分析[J].中国医院用药评价与分析,2008,8(3):224-226. 被引量:21
  • 10Vaishampayan UN, Ben - Josef E, Philip P, et al. A single - institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignaneiesl [ J ]. lnt J Radiat Oncol Biol Phys, 2002, 53(3) :675.

二级参考文献22

  • 1王涛,江泽飞,宋三泰,申戈,张少华,张志强,曾敏.希罗达治疗乳腺癌所致手足综合征的发生规律及临床处理[J].癌症进展,2004,2(4):258-260. 被引量:67
  • 2东文霞.恶性肿瘤患者放疗的副作用及其护理对策[J].护士进修杂志,2004,19(12):1140-1141. 被引量:33
  • 3黄雪珍,吴晖,王剑峰,毛雪华,何勇.优福定、依托泊甙、顺铂(FEP方案)与5-氟尿嘧啶、阿霉素、丝裂霉素(FAM方案)治疗晚期胃癌临床对照研究[J].新药与临床,1994,13(6):325-327. 被引量:2
  • 4朱慰祺 沈铭昌 廉养德 等.胃癌[A].见:汤钊猷主编.现代肿瘤学:第2版[C].上海:上海医科大学出版社,2000.710~712.
  • 5Bomgren H,lax I,Naslund I,et al.Stereotactic high dose fraction radiation therapy of extracranial tumors using and accelerator[J].(clinical experience of the first thirty-one patients)Acto Oncol,1995,34:861-870.
  • 6Lax I,Blomgron H,Naslund I,et al.Stereotactic radiotherapy of malignancies in the abdomen,methodological aspects[J].Acta Oncol,1994,33(6):677-683.
  • 7高汝贵,李光.消化道肿瘤[M]//刘泰福.现代放射肿瘤学.上海:复旦大学出版社,2001:381.
  • 8Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys, 2002, 52:283-293.
  • 9Minsky BD. The role of radiation theraphy in gastric carcinoma. Semin Oncol, 1996, 23:390-396.
  • 10Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failute in a re-operation series(second or symptomatic looks). Clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys, 1982, 8 ; 1-11.

共引文献78

同被引文献79

引证文献14

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部